ANVS Annovis Bio, Inc.
P/E
--
Forward P/E
--
Price/Sales
--
Beta
1.226
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Annovis Bio Announces Pricing of $21.0 Million Public Offering of Stock and Warrants
Annovis Bio, Inc. has priced an underwritten public offering expected to generate approximately $21.0 million in gross proceeds. The offering consists of...
Annovis Bio Stockholders Approve Doubling of Authorized Common Stock to 140 Million
Annovis Bio, Inc. announced that its stockholders have approved an amendment to the company's Certificate of Incorporation, effectively doubling the number of...
Annovis Bio reports preliminary third quarter 2026 cash balance of $2.8 million
Annovis Bio provided a preliminary liquidity update for the third quarter of 2026, disclosing a restricted cash position as it finalizes its quarterly...
Annovis Bio Receives NYSE Non-Compliance Notice Regarding Continued Listing Standards
Annovis Bio, Inc. (ANVS) announced it received a notice from the New York Stock Exchange (NYSE) on October 29, 2026, indicating non-compliance with continued...